.jpg)
To announce the expected date of the board of directors meeting to approve the consolidated financial statements is 2026/03/05 for the fourth quarter of 2025
2026.2.25
...
.jpg)
TSH Biopharm was invited to attend the institutional investor conference hosted by Reliance Securities.
2025.12.8
...
.jpg)
TSH Biopharm and Zhaoke Ophthalmology have partnered to introduce an innovative presbyopia treatment, BCSA25.
2025.12.8
...
.jpg)
Announcement on behalf of major subsidiary,CHUANG YI BIOTECH CO., LTD.regarding to change stock agency
2025.12.3
...
.jpg)
TSH Board of Directors Approved the Consolidated Financial Statements For the Nine Months Ended September 30, 2025
2025.11.11
...
